Wolfgang Strube

Area of research

Neurology · Psychiatry and Mental health

Research interest

Research focused on Schizophrenia (object-oriented programming) and Transcranial magnetic stimulation, with related work in Positive and Negative Syndrome Scale, Clozapine, Cannabis. Notable publications include 'Cannabis use and psychosis: a review of reviews', 'Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine', and 'Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized,...'.

Antipsychotic co-medication and treatment response to rTMS and iTBS in depression: Data from clinical records from two independent clinical sites

Journal of Psychopharmacology 2026cited by 0position: lastdoi

Non-invasive brain stimulation augmentation therapy for treatment-resistant schizophrenia: a systematic review and network meta-analysis

EClinicalMedicine 2025cited by 2position: middledoi

rTMS for the treatment of psychiatric disorders: a review about training courses and materials and the presentation of the training materials of the German Society for Brain Stimulation in Psychiatry

Frontiers in Psychiatry 2025cited by 0position: middledoi

Testing a Motor Score Based on PANSS Ratings: A Proxy for Comprehensive Motor Assessment

Schizophrenia Bulletin 2024cited by 5position: middledoi

Assessing the impact of sex on high-frequency repetitive transcranial magnetic stimulation´s clinical response in schizophrenia – results from a secondary analysis

The World Journal of Biological Psychiatry 2024cited by 4position: middledoi

Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial

Pharmacopsychiatry 2023cited by 12position: middledoi

Effects of high-frequency prefrontal rTMS on heart frequency rates and blood pressure in schizophrenia

Journal of Psychiatric Research 2021cited by 4position: middledoi

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

Contemporary Clinical Trials Communications 2020cited by 21position: middledoi

Cannabis use and psychosis: a review of reviews

European Archives of Psychiatry and Clinical Neuroscience 2019cited by 245position: middledoi

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

Schizophrenia Research 2019cited by 24position: middledoi

Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms – Results from an exploratory re-analysis

Psychiatry Research 2018cited by 20position: middledoi

S49. EFFICACY OF HIGH-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PANSS FACTORS IN SCHIZOPHRENIA WITH PREDOMINANT NEGATIVE SYMPTOMS – RESULTS FROM AN EXPLORATORY RE-ANALYSIS

Schizophrenia Bulletin 2018cited by 0position: middledoi

Recent publications

Grants

Frequent collaborators